Neurofocus growth Lundbeck is a long-standing biopharma specializing in brain health with global reach, presenting opportunities to offer CNS-targeted services, digital health partnerships, and regional market expansion support in over 80 countries.

AI-enabled ops The appointment of a Chief AI Officer and active AI initiatives suggest a readiness to adopt advanced analytics, data platforms, and automation. This creates upsell potential for AI-driven R&D data management, real-world evidence analytics, and commercial operations optimization tools.

Neurology partnerships Active engagement in neurology events and phase-focused pipelines (migraine, Parkinson’s) indicate opportunities to propose clinical trial partnerships, investigator networks, patient recruitment services, and real-world outcomes research collaborations.

Global expansion With presence in 20+ countries and products in 80+ markets, there is scope for regional market access consulting, regulatory affairs support, supply chain optimization, and payer strategy services tailored to diverse healthcare systems.

Digital and training Past investments in training programs and tech stack usage (SAP, Azure, ServiceNow, Qlik) imply receptiveness to digital learning platforms, ERP/CRM optimization, and data visualization dashboards to accelerate commercial and medical affairs workflows.